Pharmacotherapeutics for Nurse Practitioner Prescribers 3rd Edition by Teri Moser Woo – Test Bank
To Purchase
this Complete Test Bank with Answers Click the link Below
If face any problem or
Further information contact us At tbzuiqe@gmail.com
Sample
Test
Chapter 3: Rational Drug Selection
Multiple Choice
Identify the choice that best completes the statement or answers
the question.
____ 1. An NP would prescribe the
liquid form of ibuprofen for a 6 year old because:
|
A. |
Drugs given in liquid form
are less irritating to the stomach |
|
B. |
A 6 year old may have
problems swallowing a pill |
|
C. |
Liquid forms of medication
eliminate the concern for first-pass effect |
|
D. |
Liquid ibuprofen does not
have to be dosed as often as tablet form |
____ 2. In deciding which of
multiple drugs used to use to treat a condition, the NP chooses Drug A because
it:
|
A. |
Has serious side effects
and it is not being used for a life-threatening condition |
|
B. |
Will be taken twice daily
and will be taken at home |
|
C. |
Is expensive, and is not
covered by health insurance |
|
D. |
None of these are important
in choosing a drug |
____ 3. A client asks the NP about
the differences in drug effects between men and women. What is known about the
differences between the pharmacokinetics of men and women?
|
A. |
Body temperature varies
between men and women |
|
B. |
Muscle mass is greater in
women |
|
C. |
Percentage of fat differs
between genders |
|
D. |
Proven subjective factors
exist between the genders |
____ 4. The first step in the
prescribing process according to the World Health Organization is:
|
A. |
Choosing the treatment |
|
B. |
Educating the patient about
the medication |
|
C. |
Diagnosing the patient’s
problem |
|
D. |
Starting the treatment |
____ 5. Treatment goals in
prescribing should:
|
A. |
Always be curative |
|
B. |
Be patient-centered |
|
C. |
Be convenient for the
provider |
|
D. |
Focus on the cost of
therapy |
____ 6. The therapeutic goals when
prescribing include(s):
|
A. |
Curative |
|
B. |
Palliative |
|
C. |
Preventive |
|
D. |
All of the above |
____ 7. When determining drug
treatment the NP prescriber should:
|
A. |
Always use evidence-based
guidelines |
|
B. |
Individualize the drug
choice for the specific patient |
|
C. |
Rely on his or her
experience when prescribing for complex patients |
|
D. |
Use the newest drug on the
market for the condition being treated |
____ 8. Patient education
regarding prescribed medication includes:
|
A. |
Instructions written at the
high school reading level |
|
B. |
Discussion of expected
adverse drug reactions |
|
C. |
How to store leftover
medication such as antibiotics |
|
D. |
Verbal instructions always
in English |
____ 9. Passive monitoring of drug
effectiveness includes:
|
A. |
Therapeutic drug levels |
|
B. |
Adding or subtracting
medications from the treatment regimen |
|
C. |
Ongoing provider visits |
|
D. |
Instructing the patient to report
if the drug is not effective |
____ 10. Pharmacokinetic factors that affect
prescribing include:
|
A. |
Therapeutic index |
|
B. |
Minimum effective
concentration |
|
C. |
Bioavailability |
|
D. |
Ease of titration |
____ 11. Pharmaceutical promotion may affect
prescribing. To address the impact of pharmaceutical promotion, the following
recommendations have been made by the Institute of Medicine:
|
A. |
Conflicts of interest and
financial relationships should be disclosed by those providing education. |
|
B. |
Providers should ban all
pharmaceutical representatives from their office setting. |
|
C. |
Drug samples should be used
for patients who have the insurance to pay for them, to ensure the patient
can afford the medication. |
|
D. |
Providers should only accept
low-value gifts, such as pens and pads of paper, from the pharmaceutical
representative. |
Chapter 3: Rational Drug Selection
Answer Section
MULTIPLE CHOICE
1. ANS:
B
PTS: 1
2. ANS:
B
PTS: 1
3. ANS:
C
PTS: 1
4. ANS:
C
PTS: 1
5. ANS:
B
PTS: 1
6. ANS:
D
PTS: 1
7. ANS:
B
PTS: 1
8. ANS:
B
PTS: 1
9. ANS:
D
PTS: 1
10. ANS:
C
PTS: 1
11. ANS:
A
PTS: 1
Chapter 4: Legal and Professional Issues in Prescribing
Multiple Choice
Identify the choice that best completes the statement or answers
the question.
____ 1. The U.S. Food and Drug
Administration (FDA) regulates:
|
A. |
Prescribing of drugs by MDs
and NPs |
|
B. |
The official labeling for
all prescription and over-the-counter drugs |
|
C. |
Off-label recommendations
for prescribing |
|
D. |
Pharmaceutical educational
offerings |
____ 2. The U.S. Food and Drug
Administration (FDA) approval is required for:
|
A. |
Medical devices, including
artificial joints |
|
B. |
Over-the-counter vitamins |
|
C. |
Herbal products, such as St
John’s Wort |
|
D. |
Dietary supplements, such
as Ensure |
____ 3. An Investigational New
Drug (IND) is filed with the FDA:
|
A. |
When the manufacturer has
completed Phase III trials |
|
B. |
When a new drug is
discovered |
|
C. |
Prior to animal testing of
any new drug entity |
|
D. |
Prior to human testing of
any new drug entity |
____ 4. Phase IV clinical trials
in the United States are also known as:
|
A. |
Human bioavailability
trials |
|
B. |
Post-marketing research |
|
C. |
Human safety and efficacy
studies |
|
D. |
The last stage of animal
trials before the human trials begin |
____ 5. Off-label prescribing is:
|
A. |
Regulated by the FDA |
|
B. |
Illegal by NPs in all
states (provinces) |
|
C. |
Legal if there is
scientific evidence for the use |
|
D. |
Regulated by the Drug Enforcement
Administration (DEA) |
____ 6. The U.S. Drug Enforcement
Administration (DEA):
|
A. |
Registers manufacturers and
prescribers of controlled substances |
|
B. |
Regulates NP prescribing at
the state level |
|
C. |
Sanctions providers who prescribe
drugs off-label |
|
D. |
Provides prescribers with a
number they can use for insurance billing |
____ 7. Drugs that are designated
Schedule II by the DEA:
|
A. |
Are known teratogens during
pregnancy |
|
B. |
May not be refilled; a new
prescription must be written |
|
C. |
Have a low abuse potential |
|
D. |
May be dispensed without a
prescription unless regulated by the state |
____ 8. Precautions that should be
taken when prescribing controlled substances include:
|
A. |
Faxing the prescription for
a Schedule II drug directly to the pharmacy |
|
B. |
Using tamper-proof paper
for all prescriptions written for controlled drugs |
|
C. |
Keeping any pre-signed
prescription pads in a locked drawer in the clinic |
|
D. |
Using only numbers to
indicate the amount of drug to be prescribed |
____ 9. Strategies prescribers can
use to prevent misuse of controlled prescription drugs include:
|
A. |
Use of chemical dependency
screening tools |
|
B. |
Firm limit-setting
regarding prescribing controlled substances |
|
C. |
Practicing “just say no” to
deal with patients who are pushing the provider to prescribe controlled
substances |
|
D. |
All of the above |
____ 10. Behaviors predictive of addiction to
controlled substances include:
|
A. |
Stealing or borrowing
another patient’s drugs |
|
B. |
Requiring increasing doses
of opiates for pain associated with malignancy |
|
C. |
Receiving refills of a
Schedule II prescription on a regular basis |
|
D. |
Requesting that only their
own primary care provider prescribe for them |
____ 11. Medication agreements or “Pain
Medication Contracts” are recommended to be used:
|
A. |
Universally for all
prescribing for chronic pain |
|
B. |
For patients who have
repeated requests for pain medication |
|
C. |
When you suspect a patient
is exhibiting drug-seeking behavior |
|
D. |
For patients with pain
associated with malignancy |
____ 12. A prescription needs to be written
for:
|
A. |
Legend drugs |
|
B. |
Most controlled drugs |
|
C. |
Medical devices |
|
D. |
All of the above |
Chapter 4: Legal and Professional Issues in Prescribing
Answer Section
MULTIPLE CHOICE
1. ANS:
B
PTS: 1
2. ANS:
A
PTS: 1
3. ANS:
D
PTS: 1
4. ANS:
B
PTS: 1
5. ANS:
C
PTS: 1
6. ANS:
A
PTS: 1
7. ANS:
B
PTS: 1
8. ANS:
B
PTS: 1
9. ANS:
D
PTS: 1
10. ANS:
A
PTS: 1
11. ANS:
A
PTS: 1
12. ANS:
D
PTS: 1
Chapter 50: Pediatric Patients
Multiple Choice
Identify the choice that best completes the statement or answers
the question.
____ 1. The Pediatric Research
Equity Acts requires:
|
A. |
All children be provided equal
access to drug research trials |
|
B. |
Children to be included in
the planning phase of new drug development |
|
C. |
That pediatric drug trials
guarantee children of multiple ethnic groups are included |
|
D. |
All applications for new
active ingredients, new indications, new dosage forms, or new routes of
administration require pediatric studies |
____ 2. The Best Pharmaceuticals
for Children Act:
|
A. |
Includes a pediatric
exclusivity rule which extends the patent on drugs studied in children |
|
B. |
Establishes a committee
that writes guidelines for pediatric prescribing |
|
C. |
Provides funding for new
drug development aimed at children |
|
D. |
Encourages manufacturers
specifically to develop pediatric formulations |
____ 3. The developmental
variation in Phase I enzymes has what impact on pediatric prescribing?
|
A. |
None, Phase I enzymes are
stable throughout childhood. |
|
B. |
Children should always be
prescribed lower than adult doses per weight due to low enzyme activity until
puberty. |
|
C. |
Children should always be
prescribed higher than adult doses per weight due to high enzyme activity. |
|
D. |
Prescribing dosages will
vary based on the developmental activity of each enzyme, at times requiring
lower than adult doses and other times higher than adult doses based on the
age of the child. |
____ 4. Developmental variation in
renal function has what impact on prescribing for infants and children?
|
A. |
Lower doses of renally
excreted drugs may be prescribed to infants younger than age 6 months. |
|
B. |
Higher doses of water
soluble drugs may need to be prescribed due to increased renal excretion. |
|
C. |
Renal excretion rates have
no impact on prescribing. |
|
D. |
Parents need to be
instructed on whether drugs are renally excreted or not. |
____ 5. Topical corticosteroids
are prescribed cautiously in young children due to:
|
A. |
They may cause an intense
hypersensitivity reaction |
|
B. |
Hypothalamic-pituitary-adrenal
(HPA) axis suppression |
|
C. |
Corticosteroids are less
effective in young children |
|
D. |
Young children may
accumulate corticosteroids leading to toxic levels |
____ 6. Liza is breastfeeding her
2-month-old son and has an infection that requires an antibiotic. What drug
factors influence the effect of the drug on the infant?
|
A. |
Maternal drug levels |
|
B. |
Half-life |
|
C. |
Lipid-solubility |
|
D. |
All of the above |
____ 7. Drugs that are absolutely
contraindicated in lactating women include:
|
A. |
Selective serotonin
reuptake inhibitors |
|
B. |
Antiepileptic drugs such as
carbamazepine |
|
C. |
Antineoplastic drugs such
as methotrexate |
|
D. |
All of the above |
____ 8. Zia is a 4 month old with
otitis media. Education of his parents regarding administering oral antibiotics
to an infant includes:
|
A. |
How to administer an oral
drug using a medication syringe |
|
B. |
Mixing the medication with
a couple ounces of formula and putting it in a bottle |
|
C. |
Discontinuing the
antibiotic if diarrhea occurs |
|
D. |
Calling for an antibiotic
change if the infant chokes and sputters during administration |
____ 9. To increase adherence in
pediatric patients a prescription medication should:
|
A. |
Have a short half-life |
|
B. |
Be the best tasting of the
effective drugs |
|
C. |
Be the least concentrated
form of the medication |
|
D. |
Be administered 3 or 4
times a day |
____ 10. Janie is a 5-month-old breastfed
infant with a fever. Treatment for her fever may include:
|
A. |
“Baby” aspirin |
|
B. |
Acetaminophen suppository |
|
C. |
Ibuprofen suppository |
|
D. |
Alternating acetaminophen
and ibuprofen |
Chapter 50: Pediatric Patients
Answer Section
MULTIPLE CHOICE
1. ANS:
D
PTS: 1
2. ANS:
B
PTS: 1
3. ANS:
D
PTS: 1
4. ANS:
A
PTS: 1
5. ANS:
B
PTS: 1
6. ANS:
D
PTS: 1
7. ANS:
C
PTS: 1
8. ANS:
A
PTS: 1
9. ANS:
B
PTS: 1
10. ANS:
B
PTS: 1
Comments
Post a Comment